Real-time enrollment status for this low-grade glioma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:56 AM UTC
| NCT Number | NCT04166409 |
| Recruiting Status | Recruiting |
| Condition | Low-Grade Glioma |
| Phase | PHASE3 |
| Target Enrollment | 170 participants |
| Active Locations | 124 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | June 17, 2026 (Jun 17, 2026) |
As of July 17, 2026: Clinical trial NCT04166409 is currently recruiting participants. This phase3 study for low-grade glioma is actively seeking new participants at 124 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04166409 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 124 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04166409 was last updated Jun 17, 2026 (June 17, 2026). HelloStudys verifies this status automatically.